GlassScriptPhysician profile
Thomas D Riley
NPI 1558681817
$6,139.87
in general payments reported to CMS, 2019-2025
23 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,360 · 2020: $583 · 2021: $406 · 2022: $717 · 2023: $59.41 · 2024: $699 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049 · Travel and Lodging: $24.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.82 |
| Travel and Lodging | $24.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,492.53 | 2019-2021 | |
| Arthrosurface Incorporated | $1,325.67 | 2019-2020 | |
| Smith+Nephew, INC. | $554.23 | 2019-2020 | |
| Anika Therapeutics, INC. | $525.25 | 2021-2024 | Integrity, Revomotion, Glenojet |
| Exactech, INC. | $515.36 | 2020-2023 | |
| Stryker Corporation | $384.26 | 2019-2022 | |
| Nevro Corp. | $258.08 | 2024 | Senza |
| Depuy Synthes Sales INC. | $217.05 | 2021-2025 | Orthocord, Truespan Orthocord |
| Medtronic, INC. | $201.93 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Pacira Therapeutics, INC. | $199.50 | 2019 | |
| Embody, INC. | $145.52 | 2021-2022 | |
| Medacta USA, INC. | $57.02 | 2019 | |
| Ebi, LLC | $56.97 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Baudax Bio INC. | $45.11 | 2022 | |
| Sun Pharmaceutical Industries INC. | $28.31 | 2023 | Ilumya |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $22.16 | 2025 | |
| Si-Bone, INC. | $21.57 | 2025 | |
| Horizon Therapeutics Plc | $17.22 | 2019 | |
| Olympus America INC. | $15.91 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.77 | 2024 | Zilretta, Exparel |
| Astrazeneca Pharmaceuticals LP | $15.73 | 2019 | |
| Painteq LLC | $12.72 | 2022 | |
| Arthrex, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.